M1A.221
Drug-induced chronic gout, right elbow
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced chronic gout is a form of gout that occurs as a result of long-term use of certain medications, leading to the buildup of uric acid crystals in joints. When this condition affects the right elbow, it can cause persistent pain, swelling, and joint damage. Gout is a type of inflammatory arthritis characterized by sudden and severe attacks of pain, redness, and swelling, typically involving the big toe but also affecting other joints like the elbow. Chronic gout indicates ongoing, long-term inflammation that can result in joint deformities if not properly managed. This specific condition, identified by the ICD-10 code M1A.221, highlights gout caused directly by drugs and localized to the right elbow.
Causes & Symptoms
Clinical Causes: Prolonged use of medications that impair uric acid excretion, such as diuretics, low-dose aspirin, or certain immunosuppressants. Medications that increase uric acid production, like certain chemotherapy agents or nicotinic acid. Underlying metabolic conditions that predispose to hyperuricemia, exacerbated by drug effects. Chronic use of drugs leading to elevated uric acid levels, which then precipitate crystals within the joints.
Key Symptoms: Persistent swelling and redness in the right elbow. Recurrent attacks of severe joint pain, especially during flares. Limited range of motion due to joint stiffness and swelling. Tenderness and warmth over the affected elbow joint. Formation of tophi, which are nodular deposits of uric acid crystals in and around the joint. Possible skin discoloration and ulceration over the affected area in advanced cases.
Diagnostic & Treatment
Diagnosis Path: Medical history review, including medication use and symptom timeline. Physical examination of the elbow for signs of inflammation, swelling, and tophi. Blood tests measuring serum uric acid levels. Joint aspiration to obtain synovial fluid for crystal analysis under a microscope, confirming needle-shaped monosodium urate crystals. Imaging studies such as X-rays or ultrasound to identify joint damage or uric acid deposits.
Treatment Protocols: Discontinuing or adjusting the medication contributing to uric acid buildup under medical supervision. Use of medications to manage acute gout attacks, including nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. Long-term urate-lowering therapy, such as allopurinol or febuxostat, to reduce serum uric acid levels. Lifestyle modifications, including dietary changes to limit intake of purine-rich foods, alcohol, and fructose-sweetened beverages. Regular monitoring of uric acid levels to avoid future flare-ups. Physical therapy or joint support to improve elbow functionality and prevent further joint damage.
Clinical Advice & FAQs
Billing Guidance
Is M1A.221 a billable ICD-10 code?
Yes, M1A.221 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.221?
Clinical documentation must specify the nature of Drug-induced chronic gout, right elbow and any associated comorbidities for accurate reporting.
Cite this Clinical Reference